Includes bibliographical references (p. 727-850) and indexes.
|Statement||edited by Jack D. Maser and C. Robert Cloninger.|
|Contributions||Maser, Jack D., Cloninger, C. Robert.|
|LC Classifications||RC537 .C643 1990|
|The Physical Object|
|Pagination||xvii, 869 p. :|
|Number of Pages||869|
|LC Control Number||89017681|
Comorbidity of Mood and Anxiety Disorders brings together the latest information about psychiatric comorbidity, and presents a systematic examination of the co-occurrence of different symptoms and syndromes in patients with disorders of anxiety or mood. This comprehensive volume provides readers with a thorough, systematic examination of both Format: Hardcover. ISBN: OCLC Number: Description: xvii, pages: illustrations ; 24 cm: Contents: Introduction. Comorbidity of anxiety and mood. For decades, mood and anxiety disorders were considered distinct and unrelated groups of disorders. In retrospect, from almost every vantage point—including preclinical and clinical laboratory studies (1, 2), careful clinical observation, and standardized methods to evaluate both symptomatic and syndromal overlap —this “separist” view is not supported by the available by: Although such a statistic has caused some to question whether social anxiety disorder is a unique type of psychopathology, rather than a prodromal expression of another disorder, it should be noted that many studies find rates of comorbidity that are even higher in other anxiety and mood disorders (e.g., Grant et al., ).
The following chapter reviews existing research examining the relationship between anxiety and mood disorders, substance use disorders, and chronic pain. Each section provides a comprehensive review of existing research on the etiology and treatment of these comorbidities, as well as provides a framework for future : Andrew H. Rogers, Sarah T. Wieman, Amanda W. Baker. Prevalence of Comorbid Anxiety and Substance Use Disorders. Anxiety and substance use disorders are among the most frequent psychiatric problems in the United States, with lifetime rates of % and %, respectively. 1 The presence of an anxiety or substance use disorder is also a risk factor for the presence of the other disorder, as shown in both epidemiological Cited by: OCLC Number: Description: pages: illustrations. Contents: What is comorbidity --fact or artefact?--Critical issues in the evaluation of comorbidity of psychiatric disorders --Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey --Comorbidity of mood disorders: a longitudinal prospective study . Current and Lifetime Comorbidity of the DSM-IV Anxiety and Mood Disorders in a Large Clinical Sample Timothy A. Brown, Laura A. Campbell, Cassandra L. Lehman, Jessica R. Grisham, and Richard B. Mancill Boston University The comorbidity of current and lifetime DSM-IV anxiety and mood disorders was examined in 1,
Patients with psychotic disorders had the greatest difference in positive psychosis items compared to non-patients (beta = , 95 % CI: ), Author: Charles B Nemeroff. Book Forum ANXIETY AND MOOD DISORDERS Mood Disorders Across the Life Span, edited by Kenneth I. Shulman, Mauricio Tohen, and Stanley P. Kutcher. New York, Wiley-Liss, , pp., $ With no sign of the Age of Narcissism receding, the Age of Mood is surely upon us. Comorbidity, perhaps. Only the pro-. In Chapter 6, we will discuss matters related to mood disorders to include their clinical presentation, epidemiology, comorbidity, etiology, and treatment options. Our discussion will include Major Depressive Disorder, Persistent Depressive Disorder (formerly called Dysthymia), Bipolar I Disorder, Bipolar II Disorder, and Cyclothymic Disorder. The high comorbidity rate among anxiety-related disorders and substance-related disorders is likely related to the efforts of self-medicating. For example, an individual with social anxiety disorder may consume larger amounts of alcohol in social settings in efforts to alleviate the anxiety of the social situation. Treatment Exposure.